Published in Br Med J on January 17, 1970
Felty's syndrome. A clinical and pathological survey of 21 patients and their response to treatment. Ann Rheum Dis (1971) 2.65
Hepatic manifestations of autoimmune rheumatic diseases. Ann Rheum Dis (2004) 2.35
Raised serum alkaline phosphatase in rheumatoid disease. An index of liver dysfunction? Ann Rheum Dis (1970) 1.67
Liver disease in rheumatoid arthritis and Sjøgren's syndrome. Prospective study using biochemical and serological markers of hepatic dysfunction. Ann Rheum Dis (1975) 1.66
Cryoglobulinaemia in tropical splenomegaly syndrome. Clin Exp Immunol (1973) 1.42
Portal hypertension--25 years of progress. Gut (1991) 1.24
Liver disease in patients with joint symptoms. Ann Rheum Dis (1974) 1.23
Rheumatoid arthritis: extra-articular manifestations. II. Br Med J (1970) 1.09
Studies of a popliteal synovial fistula. Ann Rheum Dis (1972) 1.01
Nodular, non-cirrhotic liver associated with portal hypertension in a patient with rheumatoid arthritis. J Clin Pathol (1974) 0.99
Clinical associations between arthritis and liver disease. Ann Rheum Dis (1982) 0.98
Portal circulation and portal hypertension. Gut (1978) 0.89
Gastrointestinal and hepatic manifestations of rheumatoid arthritis. Dig Dis Sci (2011) 0.84
Familial Felty's syndrome. Ann Rheum Dis (1976) 0.80
Felty's syndrome associated with high levels of IgA rheumatoid factor. Ann Rheum Dis (1984) 0.80
Oesophageal variceal bleeding in Felty's syndrome associated with nodular regenerative hyperplasia. Ann Rheum Dis (1978) 0.80
Portal hypertension in a patient with chronic myeloid leukaemia. Postgrad Med J (1977) 0.79
Nodular regenerative hyperplasia of the liver: diagnosis by liver biopsy. Can Med Assoc J (1980) 0.76
Systemic lupus erythematosus and nodular regenerative hyperplasia of the liver. Ann Rheum Dis (1986) 0.75
Vasculitis in gastrointestinal and hepatic disorders. Proc R Soc Med (1970) 0.75
An unusual cause of variceal haemorrhage in an elderly patient. Postgrad Med J (1984) 0.75
Amyloidosis in rheumatoid arthritis. J Pathol Bacteriol (1956) 2.85
Splenectomy in blood dyscrasias. N Engl J Med (1950) 2.46
Estimation of hepatic blood flow with indocyanine green. J Clin Invest (1962) 2.30
FOLIC-ACID DEFICIENCY IN RHEUMATOID ARTHRITIS. Br Med J (1964) 2.29
Portal hypertension in idiopathic tropical splenomegaly. Lancet (1966) 2.16
A correlative study of the erythrokinetics and disturbances in iron metabolism associated with the anemia of rheumatoid arthritis. Blood (1959) 2.13
Anemia and the spleen. N Engl J Med (1958) 1.75
Fluorescent antiglobulin studies in leukopenic and related disorders. J Clin Invest (1959) 1.71
Splenic blood flow in cirrhosis and portal hypertension. Clin Sci (1968) 1.68
HAEMODILUTION ANAEMIA ASSOCIATED WITH SIMPLE SPLENIC HYPERPLASIA. Lancet (1964) 1.55
Direct splenic arterial and venous blood studies in the hypersplenic syndromes before and after epinephrine. Blood (1951) 1.37
The liver in rheumatoid arthritis. Ann Rheum Dis (1955) 1.32
Splenectomy in Felty's syndrome. Ann Intern Med (1966) 1.29
Dilution anemia corrected by splenectomy in Gaucher's disease. Ann Intern Med (1963) 1.29
ANAEMIA OF FELTY'S SYNDROME. Ann Rheum Dis (1964) 1.24
Liver biopsy in rheumatoid arthritis. Am J Med Sci (1953) 1.19
Radiological determination of spleen size. Gut (1969) 1.13
Therapy of Felty's syndrome. Ann Rheum Dis (1955) 1.01
Morphological observations on livers and spleens of patients with tropical splenomegaly in New Guinea. J Pathol Bacteriol (1968) 0.95
EXPERIMENTAL AUGMENTATION OF PORTAL BLOOD FLOW. Ann Surg (1964) 0.86
Transection of the oesophagus for bleeding oesophageal varices. Br J Surg (1973) 26.26
Recognition of the fetal alcohol syndrome in early infancy. Lancet (1973) 8.57
Pattern of malformation in offspring of chronic alcoholic mothers. Lancet (1973) 7.45
Early indicators of prognosis in fulminant hepatic failure. Gastroenterology (1989) 7.43
Cost analysis of early discharge after hip fracture. BMJ (1993) 6.64
Deaths from low dose paracetamol poisoning. BMJ (1998) 6.63
Anti-tuberculous therapy and acute liver failure. Lancet (1995) 6.27
Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med (2000) 6.07
Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med (2001) 6.05
Birth outcomes in pregnant women taking fluoxetine. N Engl J Med (1996) 5.38
Acute liver failure: redefining the syndromes. Lancet (1993) 4.99
Vulnerability genes or plasticity genes? Mol Psychiatry (2009) 4.96
Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false-positive result? Lancet (1990) 4.57
Urinary D-glucaric-acid excretion as a test for hepatic enzyme induction in man. Lancet (1971) 4.49
Liver transplantation in man. I. Observations on technique and organization in five cases. Br Med J (1968) 4.38
Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine. Lancet (1990) 4.27
Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med (1996) 4.10
Daily variation of particulate air pollution and poor cardiac autonomic control in the elderly. Environ Health Perspect (1999) 4.07
Cell-mediated immunity to a human liver-specific antigen in patients with active chronic hepatitis and primary biliary cirrhosis. Lancet (1972) 3.90
Iron-chelation therapy with oral deferipronein patients with thalassemia major. N Engl J Med (1995) 3.88
A simple method of measuring breath hydrogen in carbohydrate malabsorption by end-expiratory sampling. Clin Sci Mol Med (1976) 3.87
The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. J Exp Med (2000) 3.78
Inadequate antibody response to hBAg or suppressor T-cell defect in development of active chronic hepatitis. Lancet (1974) 3.61
Screening for type 2 diabetes: literature review and economic modelling. Health Technol Assess (2007) 3.40
Structured patient education: the diabetes X-PERT Programme makes a difference. Diabet Med (2006) 3.36
The nitric oxide hypothesis and the hyperdynamic circulation in cirrhosis. Hepatology (1994) 3.29
Detection of antibodies directed against a liver-specific membrane lipoprotein in patients with acute and chronic active hepatitis. N Engl J Med (1978) 3.28
Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome. N Engl J Med (1992) 3.24
NHLBI Family Heart Study: objectives and design. Am J Epidemiol (1996) 3.21
Lymphocyte cytotoxicity to isolated hepatocytes in chronic active hepatitis. Nature (1974) 3.17
Purification and characterization of human liver-specific membrane lipoprotein (LSP). Clin Exp Immunol (1977) 3.13
Improved survival after orthotopic liver grafting. Br Med J (Clin Res Ed) (1981) 3.09
Specificity of T lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: evidence that T cells are directed against HBV core antigen expressed on hepatocytes. J Immunol (1982) 3.09
Mutations that alter the ability of the Escherichia coli cyclic AMP receptor protein to activate transcription. Nucleic Acids Res (1990) 3.08
Presence of a newly described human DNA virus (TTV) in patients with liver disease. Lancet (1998) 3.06
Liver transplantation for malignant disease. Results in 93 consecutive patients. Ann Surg (1988) 3.04
Controlled trial of prednisone and azathioprine in active chronic hepatitis. Lancet (1973) 2.98
Use of partial cardiopulmonary bypass during the anhepatic phase of orthotopic liver grafting. Lancet (1979) 2.98
Older paternal age and fresh gene mutation: data on additional disorders. J Pediatr (1975) 2.97
Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial. BMJ (1991) 2.94
More donor organs for transplantation. Elective ventilation proposals. J R Coll Physicians Lond (1993) 2.91
Multisystem involvement in chronic liver disease. Studies on the incidence and pathogenesis. Am J Med (1973) 2.88
Altered calcium metabolism in epileptic children on anticonvulsants. Br Med J (1971) 2.86
The arthropathy of idiopathic haemochromatosis. Q J Med (1968) 2.85
Hepatitis B virus infection in medical and health care personnel. Br Med J (Clin Res Ed) (1982) 2.85
Liver transplantation after paracetamol overdose. BMJ (1991) 2.81
New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a. J Clin Microbiol (1997) 2.78
Liver disease and bile duct abnormalities in adults with cystic fibrosis. Lancet (1989) 2.76
Hepatic damage and death from overdose of paracetamol. Lancet (1973) 2.70
Extrahepatic biliary atresia versus neonatal hepatitis. Review of 137 prospectively investigated infants. Arch Dis Child (1976) 2.67
Cyclosporin A in cadaveric organ transplantation. Br Med J (Clin Res Ed) (1981) 2.67
Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. N Engl J Med (1991) 2.65
Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection. Gastroenterology (1999) 2.62
Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology (1988) 2.60
Relationships of upper gastrointestinal motor and sensory function with glycemic control. Diabetes Care (2001) 2.60
Treatment of hepatic encephalopathy. N Engl J Med (1997) 2.60
Liver transplantation. Curr Probl Surg (1979) 2.57
Sarafotoxin S6c: an agonist which distinguishes between endothelin receptor subtypes. Biochem Biophys Res Commun (1991) 2.54
Treatment of fulminant hepatic failure by polyacrylonitrile-membrane haemodialysis. Lancet (1977) 2.53
Massively parallel 454 sequencing indicates hyperdiverse fungal communities in temperate Quercus macrocarpa phyllosphere. New Phytol (2009) 2.53
Acute liver failure secondary to hepatic infiltration: a single centre experience of 18 cases. Gut (1998) 2.51
Orthotopic liver transplantation: the first 60 patients. Br Med J (1977) 2.50
A habitable fluvio-lacustrine environment at Yellowknife Bay, Gale crater, Mars. Science (2013) 2.50
The systemic inflammatory response syndrome in acute liver failure. Hepatology (2000) 2.47
The amniotic band disruption complex: timing of amniotic rupture and variable spectra of consequent defects. J Pediatr (1979) 2.46
Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms. Hepatology (2000) 2.45
Attentional bias in anxiety and depression: the role of awareness. Br J Clin Psychol (1995) 2.43
Developing and deploying a patient safety program in a large health care delivery system: you can't fix what you don't know about. Jt Comm J Qual Improv (2001) 2.42
Antibodies to the surface of halothane-altered rabbit hepatocytes in patients with severe halothane-associated hepatitis. N Engl J Med (1980) 2.41
Azathioprine for long-term maintenance of remission in autoimmune hepatitis. N Engl J Med (1995) 2.41
1 -Antitrypsin deficiency and neonatal hepatitis. Br Med J (1972) 2.40
General practice orthopaedic outpatient referrals in North Staffordshire. Br Med J (Clin Res Ed) (1983) 2.38
Relation of renal impairment and haemorrhagic diathesis to endotoxaemia in fulminant hepatic failure. Lancet (1974) 2.37
Draft guidance for industry extended-release solid oral dosage forms. Development, evaluation and application of in vitro-in vivo correlations. Adv Exp Med Biol (1997) 2.35
Cyclosporin A treatment in primary biliary cirrhosis: results of a long-term placebo controlled trial. Gastroenterology (1993) 2.32
Long-term anticonvulsant therapy worsens outcome in paracetamol-induced fulminant hepatic failure. Hum Exp Toxicol (1992) 2.31
Influence of delta infection on severity of hepatitis B. Lancet (1982) 2.31
Increased long-term survival in variceal haemorrhage using injection sclerotherapy. Results of a controlled trial. Lancet (1982) 2.30
Epidemiology of fetal alcohol syndrome in a South African community in the Western Cape Province. Am J Public Health (2000) 2.30
Outcome in offspring of chronic alcoholic women. Lancet (1974) 2.27
Treatment of secondary hepatic tumours by ligation of hepatic artery and infusion of cytotoxic drugs. Lancet (1970) 2.25
Cytomegalovirus hepatitis in the adult. Lancet (1967) 2.20
Serial prothrombin time as prognostic indicator in paracetamol induced fulminant hepatic failure. BMJ (1990) 2.18
Detection of hepatitis-B antigen by radioimmunoassay in chronic liver disease and hepatocellular carcinoma in Great Britain. Lancet (1973) 2.17
The organization of the araBAD operon of Escherichia coli. Gene (1986) 2.16
Assessment of non-mydriatic fundus photography in detection of diabetic retinopathy. Br Med J (Clin Res Ed) (1986) 2.16
Fasting proinsulin concentrations predict the development of type 2 diabetes. Diabetes Care (1999) 2.16
Portal hypertension in idiopathic tropical splenomegaly. Lancet (1966) 2.16
Treatment of multiple-hormone-producing malignant islet-cell tumour with streptozotocin. Lancet (1968) 2.14
Measurement and characterization of postischemic free radical generation in the isolated perfused heart. J Biol Chem (1989) 2.14
Antibiotic resistant tuberculosis in the United Kingdom: 1993-1999. Thorax (2002) 2.12
A 7-year experience of severe acetaminophen-induced hepatotoxicity (1987-1993). Gastroenterology (1995) 2.11
H2-receptor antagonists and antacids in the prevention of acute gastrointestinal haemorrhage in fulminant hepatic failure. Two controlled trials. Lancet (1977) 2.10
Reduction of absorption of paracetamol by activated charcoal and cholestyramine: a possible therapeutic measure. Br Med J (1973) 2.09
Breath-hydrogen test for small-intestinal bacterial colonisation. Lancet (1976) 2.09
Arthropathy of haemochromatosis. Clinical and radiological analysis of 63 patients with iron overload. Ann Rheum Dis (1970) 2.09
Detection, treatment, and follow up of women with Chlamydia trachomatis infection seeking abortion in inner city general practices. BMJ (1989) 2.08